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Introduction
The human microbiome as it relates to metabolic function 
and health
It has been established that communities of microorganisms, 
microbiota, reside on or within nearly every physical substrate 
on our planet (and associated artificial satellites)1–10. Com-
posed of organisms encompassing multiple divisions of the 
tree of life, such as protozoa11–16, fungi17–20, viruses21–24 and 
prokaryota25–29, these microbial communities are intricate eco-
logical structures driven by the production and exchange of 
metabolic products29–34. Indeed, these communities can cause 
metabolic cascades that have measurable influences on their 
macroscopic hosts. Through recognition of these influences, 
the importance of the microbiome as an integral component of 
human biology has come to be appreciated, not only by micro-
biologists but by clinicians and the general public. This review 
describes essential background to the human microbiome, provid-
ing an overview of microbiomes delineated by human anatomy 
within the framework of microbe–host metabolic interaction 
before focusing on these interactions as they relate to the gut.
Womb to tomb
Present from birth to death, an individual’s microbiome main-
tains a constant presence as a chimeric organ35–38. Seeding of this 
microbial system occurs at the beginning of life via transmis-
sion of a mother’s microbiome to her infant during the birthing 
process39–43. Influenced by direct environmental transmission, a 
delivered infant will inherit either the mother’s vaginal and fae-
cal microbiota as it passes through the birthing canal or the skin 
microbiota during caesarean delivery39–41. Either route of delivery 
imposes prolonged multifaceted effects on the infant44,45. Vagi-
nal birth confers a microbiome of the mother’s urogenital sys-
tem which has undergone specific alterations throughout the 
pregnancy which are conducive to the development of robust 
and functional immune and gastrointestinal (GI) systems of 
the infant42. Alternatively, numerous deleterious health effects 
for infants delivered by caesarean section have been identi-
fied. Immediate influences upon the infant include increased risk 
of exposure to antibiotic-resistant bacteria from the mother’s 
skin40. Long-term insults to health arising from caesarean deliv-
ery include greater risk of developing obesity, sensitivity to 
food and inhalant allergens, and asthma44–48. In light of increas-
ing awareness of potential negative health effects associated 
with caesarean delivery, an experimental procedure of vaginal 
seeding has been developed to simulate the microbial expo-
sures present in vaginal birth via administration of vaginal 
swabs to newly delivered infants49. However, implementing 
vaginal seeding is a contentious issue, and many clinical 
practitioners are wary of the intervention prior to extensive 
investigation of its effects50,51.
Throughout infancy, an individual’s core microbiome is con-
tinuously influenced by the mother and environment. Whether 
nourished by the mother’s natural breast milk or formula, the 
infant microbiome continues to be moulded through supplied 
nutrition. In this regard, a positive health bias towards 
biological ‘tradition’ persists, as both the process of breast 
feeding and breast milk itself, and potentially the microbes 
therein, convey health benefits superior to those of formula42,52,53. 
Progressing through infancy, the microbiome goes through 
highly variable changes, beginning to stabilise at about 2 years 
of age. Flux of the microbiome during this period is attributed to 
numerous factors, including dietary variations (for example, milk 
versus solid food), immunological development, introduction 
to novel microbes, and antibiotic exposure40,42,43,53–55.
Through the transition from infancy to childhood and onto 
adulthood, the microbiome of an individual stabilises while 
still being influenced by drug exposure29,56–59, physical 
activity60–70, the environment3 and diet21,71,72 (discussed more 
elaborately in proceeding sections)73,74. The microbiome changes 
again with old age75–77, and microbes ultimately contribute 
to decomposition after death78–80.
The human body: a microbiome perspective
Microbial communities take form within any accessible area 
of a host’s body. The defined niches with stable communi-
ties in humans and other mammals are currently generalised to 
the respiratory system20,81–84, nasal25,85,86 and oral17,25,26,87 cavi-
ties, skin22,25,26,41,88–93, vagina and urinary tract25,40,41,49,94–96, and GI 
system21,25–27,29,36–38,40,97. For each of these unique communities, 
varied challenges are involved in their sampling and analysis 
and in interpreting their impact on health or disease.
The skin
Comprising a relatively large surface area (~1.8 m2 for an adult 
human) and an array of subsystems defined by folds, crev-
ices, pH, secretion profiles, and environmental exposures, the 
skin supports highly varied microbial communities function-
ing in diverse ecological constraints (Figure 1A)89,98,99. Eco-
logical partitioning of the skin microbiome is further defined by 
elementary biological traits of the host. Microbial composition 
at specific anatomical locations coordinates with gender98,100,101. 
Indeed, topical sampling of hand palms demonstrates greater 
diversity of bacterial taxa in women than men, and specific taxa 
are differentially abundant between the two sexes100,101. Similar 
results have been presented for other body sites, such as the 
thigh and torso98,100. Expectedly, cohabitation of sexually active 
partners results in a shared skin microbiome that accurately 
matches couples 86% of the time100. Ancestral host genetics have 
also been demonstrated to influence the composition of the skin 
microbiome. Male participants of diverse ethnic backgrounds, 
all dwelling in a single geographic location, were shown to have 
microbial differences specific to ethnicity102. Furthermore, a 
study of both monozygotic and dizygotic twins described an 
association between Corynebacterium jeikeium and single- 
nucleotide polymorphisms of a host gene involved in epidermal 
barrier function103. This finding suggests that the establish-
ment of specific skin microbes is dependent on heritable factors 
of the host. Despite such associations with the skin microbiome, 
ancestral genetics have been shown to exert a negligible influ-
ence on the gut microbiome, where instead other factors, such as 
environment, play a more profound role in the form and function 
of the microbial community104.
Continuous environmental interaction unsurprisingly results in 
the skin being our most exposed microbial ecosystem. Envi-
ronmental factors shown to be influential include hygiene 
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Figure 1. Demonstration of key microbiota and metabolites of the human microbiome, delineated according to human physiology. 
(A) The skin, (B) oral cavity, (C) respiratory tract, (D) urogenital system and (E) gastrointestinal tract are each highlighted with examples of 
microbiota (Taxa) and relevant metabolic activity (Metab). Beneficial associations to host health are denoted as (+) and negative associations 
as (−).
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routines, topical medication and cosmetic use, and residential 
environment (for example, rural versus urban)89,91,98,101,105. Despite 
its vulnerability to external perturbations, an individual’s skin 
microbiome maintains a consistent core structure106. Though 
capable of opportunistic pathogenicity under certain condi-
tions, constituents of this stable community perform homeostatic 
functions and act as a barrier against transient and potentially 
pathogenic species, subsequently maintaining a role in a vari-
ety of cutaneous conditions93,106–108. Among these residential 
members are strains of Propionibacterium acnes, the fungal 
genus Malassezia, and Staphylococcus epidermidis106,108–110. 
Lipophilic P. acnes and species of Malassezia proliferate in seba-
ceous gland–rich body sites, such as the face and back89,108,109. 
The rich pool of triglycerides found in sebum are hydro-
lysed by microbes to produce fatty acids that assist in bacte-
rial adherence and maintaining an acidic pH108,111. Low pH 
environmental conditions select for lipophilic commensals 
while inhibiting colonisation by potentially pathogenic strains of 
Staphylococcus aureus and Staphylococcus pyogenes108,112. 
P. acnes additionally contributes to suppression of methicillin- 
resistant S. aureus through glycerol fermentation to short-
chain fatty acids (SCFAs) and in particular propionic acid, 
which also inhibits growth of Escherichia coli and Candida 
albicans107,112,113.
The mouth
The oral cavity microbiome represents a reasonably well-defined 
ecosystem (Figure 1B). Structure morphology and different tis-
sue types within the human mouth offer a variety of micro-
bial habitats, further delineated by conditions of oxygenation, 
pH, and nutrient availability114,115. Control of the oral micro-
biome is mediated in concert by factors produced by the host 
and the microbiota114,116–118.
Immunological training by microbiota seeded early in life ena-
bles the host to distinguish between the commensal core and 
transient pathogenic microbes, wherein selected commensals 
create biological barriers through biofilm formation, alter pH 
and oxygen levels, and produce antimicrobial molecules116,118,119. 
Bacteriocins (that is, small peptide antimicrobials that include 
the lantibiotics and microcins) are one such means of microbial- 
derived molecular regulation of community composition within 
the mouth (and other microbial systems)118. The underly-
ing mechanisms coordinating this antagonistic inter-microbe 
regulation of community structure require further elucida-
tion; however, its complexity is highlighted by findings of at 
least 1,169 putative lantibiotic gene clusters within the oral 
metagenomes defined by the Human Microbiome Project120.
Within this environment, saliva moistens the mouth, aiding in 
the mastication, swallowing and digestion of food. Saliva also 
provides an essential nutrient source for microbes, contain-
ing complex molecules such as glycoproteins (for example, 
mucins)114,116,121,122. Similarly, saliva-derived proline-rich glycopro-
teins contribute to pellicle formation on mouth surfaces, immo-
bilising microbes through their adherence to the structures114,116. 
Bioactive compounds found within saliva also include potent 
factors that inhibit growth or otherwise modify the microbial 
complex’s activity within the mouth. For example, bacte-
rial growth is curbed by lysozyme-mediated cell lysis and 
interference of glucose metabolism with lactoperoxidase- 
catalysed conversion of hydrogen peroxide and thiocyanate to 
hypothiocyanite114,116.
Sustaining a balanced oral microbiome is thought to con-
fer numerous local and systemic health benefits. Nitric oxide 
(NO) is an important cellular signalling molecule, crucially 
involved with various physiological functions: metabolism, 
nerve function, and cardiovascular function. Key oral microbi-
ome constituents have demonstrated the ability to reduce dietary 
nitrates to nitrite116,122,123. Converted nitrite is deposited into 
saliva, which is ingested after oral cavity circulation, leading to 
NO conversion and the subsequent transmission to tissues across 
the body122,123. Countering the potential health benefits of bacte-
rial nitrite supplementation, the compound may stimulate cancer 
development through formation of carcinogenic N-nitrosamines123. 
Posing a similar risk of carcinogenesis, acetaldehyde is produced 
from ethanol by oral bacteria122.
Dysfunction of the oral microbiome contributes directly to den-
tal diseases; the most widely recognised such condition is tooth 
decay or dental caries. Caries formation begins with bacterial fer-
mentation of carbohydrates to organic acids, resulting in localised 
pH reduction and subsequent tooth demineralisation114,116,119,122. 
Once the site has been acidified, the affected environment 
becomes increasingly selective for bacteria that are tolerant of 
low pH conditions, thus stimulating proliferation of destructive 
communities and worsening of the condition114,116,122. Although 
Streptococcus mutans is implicated in tooth decay, it is evident 
that no single organism is the causative agent, and instead 
polymicrobial activity drives the condition with diverse actors 
from genera such as Actinomyces, Slackia, Propionibacterium 
and Lactobacillus119.
Periodontal disease is also caused by microorganisms. Pro-
longed biofilm formation at the interface of gingival tissue and 
the tooth surface leads to the accumulation of pathogenic bacte-
ria that exacerbate inflammation through cytotoxic compounds 
such as lipopolysaccharides116,122. Resultant bleeding from 
inflammation provides a source of iron from heme, a molecule 
used by pathogenic microbes (for example, Porphyromonas 
gingivalis)116,122. Without disruption, periodontitis-associated 
microbes thrive and, with continued immunological antagonisa-
tion of the gingival tissue, contribute to induction of a dysregu-
lated inflammatory response, permanently damaging connective 
tissue and bone116,122.
The nose and respiratory system
At one time, the human lung had been considered a sterile bio-
logical system unless challenged with disease. Now, however, 
it is clear that a respiratory microbiome exists (Figure 1C).
When healthy, the lung environment reflects many char-
acteristics of the mouth and nose interiors, namely moder-
ate thermal stability, high oxygen availability, mucosa-lined 
internal surfaces, and a continuous influx of environmental 
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microbes. Despite these similarities, modern investigation of 
respiratory-related microbes in the lungs projects a microbiome 
of low phylogenetic diversity124–126. The simplicity of the lung 
microbiome contrasts with that of the oral cavity, although the 
latter acts as a major channel for microbiota translocation, and 
microaspiration of aerosolised material from the upper respira-
tory tract and direct migration along the oropharynx mucosa 
occur126,127.
Whereas some human microbial communities exhibit high lev-
els of diversity when healthy, presenting associations between 
disease and reduced diversity, the respiratory microbiome is 
thought to be more susceptible to malignancy when the complex-
ity of its composition increases25,116,126,128,129. This is observed as 
far up in the respiratory system as the nasal cavity, and elevated 
diversity of the inner nostril is associated with a number of 
allergies100. Conversely, post-surgical outcome of sinus sur-
gery is better with more diverse sinonasal microbial com-
munities, suggesting an unpredictable complex relationship 
between upper respiratory tract microbial diversity and health130. 
Ultimately, caution needs to be used when considering diversity 
as a marker of health.
A clear association between the lung microbiota and compro-
mised pulmonary health has been demonstrated with asthma, 
an inflammatory disease20,83,85,129,131,132. As is the case for many 
microbiome–health interactions, evidence supports early-
life microbial exposures as being critically influential with 
respect to respiratory health. Strong epidemiological associa-
tions assert an increased risk of inflammatory respiratory dis-
ease with caesarean birth and reduced risk from diverse antigen 
presentation (such as rural and farm exposures)46,47,133–135. More 
specifically, bacterial species of Lachnospira, Veillonella, Fae-
calibacterium and Rothia were found at low relative abun-
dance in the guts of children deemed to be at higher risk of 
developing asthma135. Other studies have highlighted differ-
ences in community complexity of airways that relate to asthma 
phenotype20,83,85,129,131,132. For example, patients with type 2-high 
(T2-high) asthma, a form of the disease marked by specific 
type 2 immunological responses, were shown to have signifi-
cantly lower diversity of fungal species in airway samples when 
compared with other patients with asthma132. The same study 
reported an enrichment of species from the Trichoderma fungal 
genus in T2-high patients. Among the extensive work carried 
out in characterising the role of microbes in asthma, associa-
tions have been made between a deviation from the typical pre-
dominance of Bacteroidetes members (for example, species of 
Prevotella) to those of Proteobacteria (for example, Haemophilus 
species)83,136,137. Given the observation that Proteobacteria are 
a predominant component of the skin microbiome, it may 
be that a detrimental transposition of skin-associated micro-
biota into the lungs plays some role in the aetiology of the 
disease100,108. Although this possibility is intriguing, more robust 
characterisation of which specific Proteobacteria species are 
present in the separate sites would be needed to further the 
theory. Similarly, some analysis of the fungal component of 
the pulmonary microbiome implicates the presence of Malas-
sezia species in asthma138. This fungal species is better known 
as a factor in atopic and seborrhoeic dermatitis, providing a 
further potential link between the deleterious translocation of 
skin microbiota and asthma110. It should be noted that these 
potential links need to be definitely established.
Although our understanding of the respiratory microbiome’s 
general role in health is continuing to evolve, there is evi-
dence of compositional alterations in the asthmatic lung micro-
biome in response to corticosteroid treatment131,137. Patients 
with asthma, regardless of whether the asthma is resistant or 
sensitive to corticosteroid treatment, show reduced Bacter-
oidetes abundance and increased levels of Proteobacteria and 
Actinobacteria species131. Additionally, host-derived periph-
eral blood monocytes from the lungs of corticosteroid-resistant 
patients had inhibited corticosteroid response when co-cultured 
with an isolate of Haemophilus parainfluenzae, a potential 
pathogen associated with asthma131.
The vagina and urinary tract
The urogenital microbiome influences female health in a vari-
ety of ways. It is also responsible for seeding the microbiome 
of infants passing through the birth canal in the case of vagi-
nal delivery. The establishment of this microbiome can have 
lifelong influences on the health of the infant43,44,139–141.
Substantial effort has been put towards characterisation of 
vaginal microbial components and associated metabolic 
function (Figure 1D). The healthy vaginal microbiome is 
characterised as maintaining low microbial diversity, and 
Lactobacillus species typically dominate25,96,142. Disruptions to the 
healthy vaginal microbiome’s stable low complexity are linked to 
severity of cervical intra-epithelial neoplasia and bacterial vagi-
nosis (BV), and the latter is also associated with an increased 
susceptibility to acquiring sexually transmitted infection, pelvic 
inflammatory disease, and preterm birth94,143–148.
Lactobacillus dominance of the vaginal microbiome appears 
to be specific to humans and contrasts greatly with levels 
found in other animals (>70% and ~1%, respectively)149. Sev-
eral theories have been proposed for the Lactobacillus-centric 
human vaginal microbiome, including a suggestion of a con-
served common function of vaginal microorganisms that in 
humans happens to be fulfilled by Lactobacillus species, and 
that these species are also adapted to the starch rich diets that 
are typical of humans149. Indeed, the diet hypothesis further sug-
gests that the high glycogen concentrations found within the 
human vaginal tract reflect dietary carbohydrate catabolism 
which is facilitated by abundant salivary amylase levels.
Irrespective of its evolutionary basis, the growth of lactoba-
cilli in the vaginal environment is supported by glycoprotein- 
and mucin-rich genital fluid and high levels of glycogen and 
α-amylase, and the latter increases the energy availability of 
glycogen through its by-products149–151. With Lactobacillus 
proliferation, the oestrogen-mediated low pH of the vagina 
is further acidified by microbial-derived lactic acid, which is 
metabolised from glycogen through anaerobic glycolysis152–157. 
Low pH (~3.5) and high lactic acid concentrations contribute in 
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conjunction with cervicovaginal fluid, a highly effective anti-
microbial and antiviral medium, to maintain a healthy vaginal 
environment155,157. With BV, when the vaginal pH rises (>4.5) 
and microbial composition shifts away from being Lactobacillus- 
dominant to allow other taxa (such as Gardnerella) to prolifer-
ate, lactic acid levels drop and a more prominent SCFA profile 
develops155. Although SCFAs are generally associated with 
health benefits, particularly in the gut, an undesirable pro-
inflammatory response appears to be induced by acetate and 
butyrate within the vaginal tract93,107,113,155,158,159.
The vaginal microbiome appears to considerably influence 
the efficacy of microbicide HIV prevention therapy94. Tenofo-
vir microbicide gel was 59.2% effective in HIV infection pre-
vention for Lactobacillus-dominant vaginal communities, but 
in individuals with a microbiome containing greater propor-
tions of Gardnerella, the prevention rate was only 18%94. Con-
trolled doses of tenofovir administered to patients with either 
Gardnerella- or Lactobacillus-oriented microbiomes showed 
significantly lower concentrations of the drug in Gardnerella-
dominated vaginal communities; indeed, detected drug con-
centration negatively correlated with Gardnerella abundance94. 
In vitro analysis demonstrated that Gardnerella and other 
BV-associated microbes efficiently metabolised the drug 
through a cleavage of an oxy-methylphosphonic acid side chain 
of the compound94.
The male urogenital tract microbiome has received less atten-
tion. However, emerging investigation of the subject suggests 
health-relevant microbial activity within this system. Circum-
cision significantly modifies microbial composition of the 
coronal sulci of the penis, decreasing the total microbial load, 
including anaerobic taxa putatively associated with BV160,161. 
Reduced HIV infection rates have independently been asso-
ciated with circumcision, but the underlying factors of this 
protective effect are unknown162.
The gut
Of the microbial communities delineated by human physiol-
ogy, those associated with the GI system have been investigated 
with the greatest intensity (Figure 1E)12,21,27,29.
Microbes travel, generally in a uni-directional manner, through 
the GI tract within ingested material, and the associated com-
munities follow a gradient of community complexity that 
peaks in the colon163–165. Once established, the gut microbi-
ome is subject to influence from a limited number of known 
factors. Perhaps the factor that most profoundly affects this com-
munity is host diet, supplying both microbes and nutrients to 
influence the microbiome’s function and composition55,72,159,166,167. 
Plant-based complex carbohydrates, which intestinal micro-
biota process with enzymes that are absent from the human 
host, are one such important dietary factor159,167,168. Through 
metabolism of these polysaccharides, microbial fermentation 
yields SCFAs, compounds with a broad range of purportedly 
profound effects on the host159,167,168.
In addition to dietary constituents, host-derived metabo-
lites can be used by the gut microbiome167,169–172. Examples 
highlighting this host–microbe interaction include bile acids 
(BAs), which, once acted upon by bacteria, can trigger complex 
host–microbe signalling cascades, and intestinal mucins, com-
pounds used by mucin specialists (for example, Akkermansia 
muciniphila), providing protective properties to the host167,169–173. 
It is worth noting that, in addition to drugs explicitly affect-
ing microorganisms (that is, antibiotics), the interaction between 
other medications and microorganisms can be key, affecting 
microbe composition and function as well as the pharmacoki-
netics of the drugs171,174–177. Indeed, an in vitro screen of more 
than 1000 pharmaceutical compounds to assess their activ-
ity against core representative strains of gut bacteria demon-
strated that growth of at least one strain was inhibited by 24% 
of compounds intended to target human cells177. Similarly, 
the type 2 diabetes drug metformin was shown to alter both 
the composition and function of the human intestinal micro-
biota, resulting in an enrichment of genes associated with 
SCFA metabolism and faecal concentrations of propionate and 
butyrate176. However, the specifics of microbial metabolic 
interactions with metformin have yet to be elucidated.
It should also be noted that drugs of intoxication (for exam-
ple, alcohol and cannabis) are indicated to interact with the 
microbiome, although studies in this field are somewhat 
rare and often limited to non-human animal models59,178–182. 
An exception to the pattern, whereby the gut microbiome 
of chronic cannabis users was investigated181, revealed that, 
in comparison with controls, chronic cannabis users had a 
13-fold reduction in the ratio of Prevotella to Bacteroides. 
Lower Prevotella abundance was further associated with poor 
cognition test performance and reduced mitochondrial ATP 
production181.
Host behaviour, and more specifically physical exercise and fit-
ness, are also recognised as potential modulators of microbial 
composition and function60–70. Illustrating the potential influ-
ence of extremes of exercise, professional athletes have been 
shown to harbour a gut microbiome that exhibits a high compo-
sitional diversity of microbial taxa and contains a gene profile 
with robust potential for environmental energy capture60,63. More 
specifically, the gut microbiome of a cohort of professional rugby 
players, in comparison with age-matched controls with simi-
lar body mass index to represent the range of body composi-
tion in the athletes, contained greater proportions of metabolic 
pathways associated with potential health benefits. These path-
ways ranged from those associated with organic cofactor and 
antibiotic biosynthesis to degradation and biosynthesis of car-
bohydrates. Such biosynthetic pathways could result in an 
increased capacity for energy utilisation by the microbiome60. 
Metabolomic profiling of the athlete gut microbiome 
revealed elevated levels of SCFAs, which (as noted above) 
are metabolites with wide health-associated attributes 
(detailed further below) and are associated with a lean body 
composition183. The faecal metabolome of these athletes also 
exhibited elevated levels of trimethylamine-N-oxide (TMAO), 
a compound that has been associated with cardiovascular dis-
ease and atherosclerosis, although these negative associa-
tions have been disputed because of the occurrence of high 
levels of TMAO in populations with a low occurrence of 
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cardiovascular disease184, and thus the significance of these find-
ings with respect to athletes has yet to be determined. From another 
study (in this instance, of the microbiome of high-performance 
cyclists), it was shown that the genus Prevotella was significantly 
associated with reported time of exercising68. The study further 
revealed higher transcriptional activity of Methanobrevibacter 
smithii genes, particularly those related to methanogenesis, in 
professional cyclists when compared with amateurs. Investi-
gation of amateur half-marathon runners demonstrated that, 
through the course of high-intensity running, significant changes 
occurred in certain taxa (for example, Coriobacteriaceae) and 
metabolites within the gut environment70. Intriguingly, the intro-
duction of exercise as a novel stimulus appears to elicit more 
subtle changes in the gut microbiome. After undergoing a 
short period (8 weeks) of moderate-intensity exercise, healthy 
but inactive adults were shown to exhibit only minor changes in 
the composition of their gut microbiome69. A separate analy-
sis of a combination of lean and obese individuals undergo-
ing a period of structured exercise conversely asserted that 
concentrations of faecal SCFAs increased in lean participants 
following exercise while an obesity-dependent shift in micro-
bial diversity was present after exercise and dissipated after a 
washout period185. In sum, it is apparent that there remains much 
to be done to completely understand the mechanisms underlying 
the interaction of exercise and the gut microbiome.
Gut microbiome analysis is carried out predominantly on the 
terminal end of the GI tract because of the relative ease with 
which samples can be non-invasively acquired as stool. These 
samples provide insight into the intestinal microbiome as 
excreted samples retain microbial cells and metabolites from 
the lumen and mucosa, although it is important to note that 
stool does not provide an exact recapitulation of the intestine’s 
various subsites163,164,186.
Systemic implication of the gut microbiome in health 
and disease
The GI system acts as the primary site for the uptake and meta-
bolic processing of nutrients. The gut accordingly contrib-
utes substantially to health regulation. As extensive evidence 
now indicates, intestinal microbes have similar significance in 
health maintenance and modulation of various disease states via 
interaction with the host’s biology and intestinal environment. 
Microbial contributions to this health dynamic are mediated 
by numerous metabolic modalities. The most prominent such 
metabolic circuit is between the microbiome and ingested nutri-
ents, whereby microbes use dietary nutrients to proliferate 
and produce metabolites, such as SCFAs, that are involved in 
cross-talk with the host (Figure 2)29,37,72,166,167,187,188.
Short-chain fatty acids
SCFAs act locally within the intestinal system but also impact 
on hepatic, neurological and immunological function158,159,188–192. 
As previously noted, microbial SCFA generation results pri-
marily from polysaccharide utilisation, although it has also 
been demonstrated that some gut microbes have the capacity to 
produce butyrate from the metabolism of protein188,193–195.
Upon excretion from microbial cells, SCFAs entering the intes-
tinal environment are used by colonocytes as an energy source 
or pass into broader circulation via the portal vein159,188. Act-
ing locally on colonocytes, butyrate is incorporated into lumi-
nal cells through diffusion or direct transport mediated by the 
Na+-coupled transporter SLC5A8159,196. Butyrate within colono-
cytes contributes to energy production through conversion to 
acetyl-CoA or alternatively inhibits histone deacetylase (HDAC) 
activity159,196,197. HDAC inhibition occurs within colorec-
tal cancer cells, wherein glucose is preferentially used as an 
energy source, leading to butyrate accumulation and the subse-
quent action upon HDAC which results in a cascade of effects 
on cell proliferation, differentiation and apoptosis159,196,197.
Propionate enters systemic circulation through the portal vein, 
where it is metabolised primarily in the liver while acetate is 
more broadly circulated, for example, crossing the blood–brain 
barrier, where it may influence satiety through action on the 
hypothalamus190. On the basis of murine studies, gut-derived 
acetate and propionate have separately been suggested to 
influence asthma159,198,199. While regulatory T–cell activity is 
enhanced by acetate-mediated inhibition of histone deacetylase 
9 (HDAC9), resulting in suppression of environmental allergen 
hypersensitivity, propionate affects lung dendritic cells, damp-
ening promotion of T helper type 2 cell–driven inflammation 
while leaving the cells’ phagocytic ability intact81,159,198–200.
Bile acids
BAs have been shown to be at the centre of a metabolic inter-
play between the host and microbes72,169,170,174,176,201–203. Following 
post-meal metabolic cues, bile released from the canalicular 
membrane of hepatocytes enters the intestinal system. Primary 
BAs, cholic acid and chenodeoxycholic acid are converted 
from cholesterol and conjugated with taurine or glycine and, 
within the context of host physiology, are used as detergents 
to allow intestinal absorption of dietary lipids and fat-soluble 
vitamins201,203,204. Microbial bile salt hydrolases (BSHs) facili-
tate the hydrolysis of conjugated BAs (CBAs), converting the 
compounds back to BAs, which permits small intestine reab-
sorption or additional metabolic processing203,204. Unconjugated 
and glycine-CBA absorption by passive diffusion and active 
transport creates a circulating pool of BAs, establishing con-
tinuous bioavailability of the compounds202–204. As detergents, 
BAs have the capacity to disrupt the lipid membrane of bacte-
rial cells, subsequently exerting considerable influence on the 
microbiome. Microbes accordingly employ myriad strategies 
to circumvent the antimicrobial action of BAs, such as outer 
membrane lipid and protein modifications203,204. In conjunction 
with BA resistance, microbial alterations to BAs, affecting the 
hydrophobicity of the compounds, also enable some microbes 
to evade lipid membrane degradation while creating an inhos-
pitable environment for competing organisms203,204. Microbial 
BSH-driven hydrolysis of CBAs to unconjugated primary BAs 
enables subsequent conversion to secondary BAs deoxycholic 
acid (DCA) and lithocholic acid203,204. DCA, in particular, accu-
mulates in the enterohepatic BA pool. Relatively high concen-
trations of DCA result from intestinal diffusion and hepatic 
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reuptake that is facilitated by the compound’s hydrophobicity 
and the human liver’s inability to rehydroxylate DCA203.
Notably, the fat- and protein-enriched ‘Western’ diet that contrib-
utes to obesity development modifies not only gut microbiome 
composition but also microbial BA pool contributions72,167,202,205,206. 
Indeed, the negative consequences of dietary insult have 
been shown to be ameliorated through intervention with BA-
binding resins207. Roux-en-Y gastric bypass surgery has 
intriguingly been shown to also have an effect on BAs, and 
serum concentrations are raised in individuals who have under-
gone the procedure when compared with obese and severely 
Figure 2. Host–microbe metabolic interaction. A simplified demonstration of the metabolic interactions between host and microbiome. The 
cross-section of the small intestine illustrates the metabolic exchange between the intestine and two taxonomic representatives (Prevotella 
spp. and Faecalibacterium prausnitzii). Polysaccharides act as an example of dietary substrate used by the microbiota for the production 
of short-chain fatty acid (butyrate and acetate). Similarly, host-derived substrate in the form of lactate presented with excretion of mucin 
from the intestine can be used by the microbiota. Within the example, acetate can be either absorbed by the intestine and subsequently the 
bloodstream where systematic influences take place or converted to butyrate, exerting a localised effect on intestinal epithelial cells. NO, 
nitric oxide.
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obese controls, suggesting that anatomical manipulation of the 
procedure modifies the dynamics of the BA pool208,209.
Among the numerous detrimental effects of obesity, evidence 
supports a role for microbial-derived DCA as a potent tumour 
promoter, contributing to the development of hepatocellular 
carcinoma and the colorectal cancer precursor colorectal 
adenomas72,202,210–212. Although the associated mechanisms 
involved have not been studied in the human gut, DCA-driven 
hepatocellular carcinoma in mice is suggested to result from the 
compound’s provocation of the senescence-associated secre-
tory phenotype (SASP) in hepatic stellate cells211. SASP is 
characterised by broad alterations in gene expression and 
secretory profile, which affect neighbouring cells through 
numerous factors, namely the release of cytokines (for exam-
ple, interleukin-1α and -1β), insulin-like growth factor–binding 
proteins, NO and reactive oxygen species and potentially the 
glycoprotein fibronectin211,213. The influence of DCA on color-
ectal tumorigenesis is proposed to mediate derangement of 
epidermal growth factor receptor–mitogen-activated protein 
kinase (EGFR-MAPK) regulation, specifically with DCA pre-
venting degradation of EGFR through calcium signalling of 
MAPK210. There is still much to be elucidated with respect to 
the interactions between gut microbes, BAs and health. Further-
more, SCFAs and BAs represent only a small component of the 
numerous bioactive compounds within the gut environment 
and thus considerable additional investigation in this area is 
needed.
Conclusions and Outlook
Examination of microbiome–host interaction has revealed the 
integral role of microbiota in health and disease. Extensive char-
acterisation of the microbiome’s taxonomic structure and asso-
ciations between states of microbial composition and aspects 
of health have established the groundwork for recognition 
of the microbiome as a component of human biology. How-
ever, the challenge now lies in elucidating the mechanisms 
underlying the associations between our microbes and health. 
Metabolic phenotyping and identification of the microbial 
metabolites interacting with the host will be pivotal to this chal-
lenge. With such knowledge, progress can be made in the 
development of defined microbial cultures (for example, probi-
otics) and substrates conducive to selective growth or function 
of microbes (for example, prebiotics) for health enhancement. 
In short, there is need and opportunity for the innovative 
deployment of metabolic phenotyping of the human micro-
biome to develop a new generation of interventions to 
improve health.
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